| Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis L Guillevin, C Pagnoux, A Karras, C Khouatra, O Aumaître, P Cohen, ... New England Journal of Medicine 371 (19), 1771-1780, 2014 | 1215 | 2014 |
| CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative F Ghiringhelli, N Larmonier, E Schmitt, A Parcellier, D Cathelin, C Garrido, ... European journal of immunology 34 (2), 336-344, 2004 | 1160 | 2004 |
| Doxorubicin eliminates myeloid-derived suppressor cells and enhances the efficacy of adoptive T-cell transfer in breast cancer D Alizadeh, M Trad, NT Hanke, CB Larmonier, N Janikashvili, B Bonnotte, ... Cancer research 74 (1), 104-118, 2014 | 443 | 2014 |
| Pathogenesis of immune thrombocytopenia S Audia, M Mahévas, M Samson, B Godeau, B Bonnotte Autoimmunity reviews 16 (6), 620-632, 2017 | 391 | 2017 |
| Brief report: inhibition of interleukin‐6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis M Samson, S Audia, N Janikashvili, M Ciudad, M Trad, J Fraszczak, ... Arthritis & Rheumatism 64 (8), 2499-2503, 2012 | 367 | 2012 |
| Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled … P Charles, B Terrier, É Perrodeau, P Cohen, S Faguer, A Huart, ... Annals of the rheumatic diseases 77 (8), 1143-1149, 2018 | 350 | 2018 |
| Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies A Fischer, J Provot, JP Jais, A Alcais, N Mahlaoui, D Adoue, N Aladjidi, ... Journal of Allergy and Clinical Immunology 140 (5), 1388-1393. e8, 2017 | 337 | 2017 |
| Heat shock protein 27 enhances the tumorigenicity of immunogenic rat colon carcinoma cell clones C Garrido, A Fromentin, B Bonnotte, N Favre, M Moutet, AP Arrigo, ... Cancer research 58 (23), 5495-5499, 1998 | 272 | 1998 |
| Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect M Malphettes, L Gérard, M Carmagnat, G Mouillot, N Vince, D Boutboul, ... Clinical Infectious Diseases 49 (9), 1329-1338, 2009 | 271 | 2009 |
| Recent advances in our understanding of giant cell arteritis pathogenesis M Samson, M Corbera-Bellalta, S Audia, E Planas-Rigol, L Martin, ... Autoimmunity reviews 16 (8), 833-844, 2017 | 239 | 2017 |
| Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis M Samson, S Audia, J Fraszczak, M Trad, P Ornetti, D Lakomy, M Ciudad, ... Arthritis & Rheumatism 64 (11), 3788-3798, 2012 | 236 | 2012 |
| Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides B Terrier, C Pagnoux, É Perrodeau, A Karras, C Khouatra, O Aumaître, ... Annals of the rheumatic diseases 77 (8), 1150-1156, 2018 | 216 | 2018 |
| Management of giant cell arteritis: recommendations of the French Study Group for Large Vessel Vasculitis (GEFA) B Bienvenu, KH Ly, M Lambert, C Agard, M Andre, Y Benhamou, ... La Revue de medecine interne 37 (3), 154-165, 2016 | 206 | 2016 |
| Imatinib mesylate inhibits CD4+ CD25+ regulatory T cell activity and enhances active immunotherapy against BCR-ABL− tumors N Larmonier, N Janikashvili, CJ LaCasse, CB Larmonier, J Cantrell, ... The Journal of Immunology 181 (10), 6955-6963, 2008 | 198 | 2008 |
| Long-term rituximab use to maintain remission of antineutrophil cytoplasmic antibody–associated vasculitis: a randomized trial P Charles, É Perrodeau, M Samson, B Bonnotte, A Néel, C Agard, A Huart, ... Annals of internal medicine 173 (3), 179-187, 2020 | 185 | 2020 |
| Vaccination recommendations for the adult immunosuppressed patient: A systematic review and comprehensive field synopsis A Lopez, X Mariette, H Bachelez, A Belot, B Bonnotte, E Hachulla, ... Journal of Autoimmunity 80, 10-27, 2017 | 162 | 2017 |
| Efficacy and safety of rituximab in common variable immunodeficiency‐associated immune cytopenias: a retrospective multicentre study on 33 patients D Gobert, JB Bussel, C Cunningham‐Rundles, L Galicier, A Dechartres, ... British journal of haematology 155 (4), 498-508, 2011 | 160 | 2011 |
| Adding azathioprine to remission‐induction glucocorticoids for eosinophilic granulomatosis with polyangiitis (Churg‐Strauss), microscopic polyangiitis, or polyarteritis nodosa … X Puéchal, C Pagnoux, G Baron, T Quémeneur, A Néel, C Agard, ... Arthritis & Rheumatology 69 (11), 2175-2186, 2017 | 158 | 2017 |
| Increase of CD4+CD25+ regulatory T cells in the peripheral blood of patients with metastatic carcinoma: a Phase I clinical trial using cyclophosphamide and immunotherapy to eliminate … S Audia, A Nicolas, D Cathelin, N Larmonier, C Ferrand, P Foucher, ... Clinical & Experimental Immunology 150 (3), 523-530, 2007 | 153 | 2007 |
| Description of 214 cases of autoimmune congenital heart block: results of the French neonatal lupus syndrome K Levesque, N Morel, A Maltret, G Baron, A Masseau, P Orquevaux, ... Autoimmunity reviews 14 (12), 1154-1160, 2015 | 151 | 2015 |
